Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-10-001989
Filing Date
2010-03-10
Accepted
2010-03-10 14:14:08
Documents
4

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT a2197140z424b5.htm 424B5 366679
2 G79627.JPG g79627.jpg GRAPHIC 9758
3 G13835.JPG g13835.jpg GRAPHIC 13892
4 G1021248.JPG g1021248.jpg GRAPHIC 5299
  Complete submission text file 0001047469-10-001989.txt   408863
Mailing Address LICHSTRASSE 35 BASEL SWITZERLAND CH 4056
Business Address LICHSTRASSE 35 BASEL SWITZERLAND V8 CH 4056
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-153696 | Film No.: 10669991
SIC: 2834 Pharmaceutical Preparations

Mailing Address 608 FIFTH AVENUE NEW YORK NY 10020
Business Address 608 FIFTH AVENUE NEW YORK NY 10020 (212)307 1122
Novartis Capital CORP (Filer) CIK: 0001443411 (see all company filings)

EIN.: 263086456 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-153696-03 | Film No.: 10669992
SIC: 6189 Asset-Backed Securities